<DOC>
	<DOCNO>NCT01294241</DOCNO>
	<brief_summary>The purpose study compare intra-individually efficacy tolerance Sericare® versus standard treatment accelerate epithelialization skin lesion patient Epidermolysis bullosa hereditaria .</brief_summary>
	<brief_title>Case Series Documentation Patients With Epidermolysis Bullosa</brief_title>
	<detailed_description>The design trial case-series documentation individual patient involve trial , assessment treatment patient without need comparison statistical analysis different group patient . A comparison Sericare® treat Epidermolysis Bullosa ( EB ) wound untreated part wound enable independent expert assess outcome treatment . Objective method apply evaluate wound heal progress , i.e. , grade epithelialization wound .</detailed_description>
	<mesh_term>Epidermolysis Bullosa</mesh_term>
	<criteria>Patients age 195 year provide write informed consent . In case minor patient , write informed consent parent legal representative available . EB Patients least one skin lesion 10 200 cm2 . prepared comply trial requirement , include follow : Application Sericare one half wound every change wound dress ; Regular clinic visit treatment period followup period ( 14 day disease recent wound 28 day disease delay wound heal start treatment ) . Negative pregnancy test woman childbearing potential perform within 7 day prior start treatment . Women childbearing potential must agree use effective method contraception ( PearlIndex &lt; 1 , e.g . hormonal contraception include combined oral contraceptive pill , transdermal patch , contraceptive vaginal ring , intrauterine device sterilization ) treatment least 6 month thereafter . Men procreative capacity must agree use effective method contraception treatment least 6 month thereafter . receive treatment systemic steroid last 30 day ; uncontrolled diabetes diabetic ulcer ; disease condition could , opinion investigator , interfere assessment safety , tolerance efficacy ; skin disorder chronic currently active Investigator considers adversely affect heal recent wound involve area examine caseseries documentation ; history clinically significant hypersensitivity trial medication surgical dressing use caseseries documentation ; know multiple allergic disorder ; take , take , investigational drug within 3 month prior screen visit ; undergoing investigation change management exist medical condition ; likely complete caseseries documentation whatever reason .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Epidermolysis bullosa</keyword>
	<keyword>Wound heal</keyword>
	<keyword>Epithelialization</keyword>
</DOC>